{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:58:25Z","timestamp":1792018705064,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Data on the burden of mumps in South Africa are limited and the epidemiology of mumps in this setting is not well understood. We present an analysis of mumps data in South Africa from 2012 to 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study included secondary data on laboratory-confirmed mumps infections from 2012 to 2017, archived at the South African National Health Laboratory Services\u2019 data repository as well as from four private laboratories. Mumps-specific immunoglobulin M (IgM) and\/or viral nucleic acid positive results represented acute infections. We used age-specific mid-year population estimates for each study year as denominators when calculating annual cumulative incidence. Seasonality was based on the season that showed a peak in infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 48,580 records obtained from the public and private sectors, 46,713 (96.2%) were from the private sector. Over the study period, there were 7494 acute infections, 7085 (94.5%) of which were recorded in the private sector. Of these 7494 infections, 3924 (52.4%) occurred in males. The proportion of samples tested that were IgM positive was 18.6% (1058\/5682) in 2012, 15% (1016\/6790) in 2013, 15.8% (1280\/8093) in 2014, 15.5% (1384\/8944) in 2015, 13.1% (1260\/9629) in 2016 and 15.8% (1496\/9442) in 2017. The cumulative incidence rate per 100,000 was highest in children between one and 9 years throughout the study period. The cumulative incidence of infections was highest in the Western Cape, Gauteng and the Northern Cape. Infections peaked in June and November.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Laboratory-confirmed mumps infections predominantly occurred in spring, affecting children below 10\u2009years of age and individuals who were male. There were fewer tests performed in the public sector compared to the private sector. Since only laboratory data was analysed our results represent and underestimate of disease burden. Further studies that include clinical data are required to provide better estimates of disease burden in South Africa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-020-08835-x","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T04:04:22Z","timestamp":1589256262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epidemiology of laboratory-confirmed mumps infections in South Africa, 2012\u20132017: a cross-sectional study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9920-5852","authenticated-orcid":false,"given":"Mpho Lerato","family":"Sikhosana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazarus","family":"Kuonza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkengafac Villyen","family":"Motaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"issue":"6","key":"8835_CR1","first-page":"503","volume":"76","author":"N Principi","year":"2018","unstructured":"Principi N, Esposito S. Mumps outbreaks: a problem in need of solutions. J Inf Secur. 2018;76(6):503\u20136.","journal-title":"J Inf Secur"},{"key":"8835_CR2","unstructured":"World Health Organization-Europe-UNICEF [Online]. Global and regional immunization profile. Last updated 10 Dec 2019. Accessed 19 Apr 2020. Available: https:\/\/www.who.int\/immunization\/monitoring_surveillance\/data\/gs_gloprofile.pdf?ua=1."},{"key":"8835_CR3","unstructured":"World Health Organization [Online]. Immunization coverage. Mumps. Last updated 6 Dec 2019. Accessed 10 Apr 2018. Available: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/immunization-coverage."},{"issue":"10","key":"8835_CR4","doi-asserted-by":"publisher","first-page":"30156","DOI":"10.2807\/1560-7917.ES.2016.21.10.30156","volume":"21","author":"S Vygen","year":"2016","unstructured":"Vygen S, Fischer A, Meurice L, Mounchetrou NI, Gregoris M, Ndiaye B, et al. Waning immunity against mumps in vaccinated young adults, France 2013. Euro Surveill. 2016;21(10):30156.","journal-title":"Euro Surveill"},{"issue":"18","key":"8835_CR5","doi-asserted-by":"publisher","first-page":"18857","DOI":"10.2807\/ese.13.18.18857-en","volume":"13","author":"S Gee","year":"2008","unstructured":"Gee S, O\u2019Flanagan D, Fitzgerald M, Cotter S. Mumps in Ireland, 2004-2008. Euro Surveill. 2008;13(18):18857.","journal-title":"Euro Surveill"},{"issue":"4","key":"8835_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3201\/eid1704.101461","volume":"17","author":"CF Yung","year":"2011","unstructured":"Yung CF, Andrews N, Bukasa A, Brown KE, Ramsay M. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerg Infect Dis. 2011;17(4):661\u20137.","journal-title":"Emerg Infect Dis"},{"key":"8835_CR7","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1056\/NEJMoa0706589","volume":"358","author":"GH Dayan","year":"2008","unstructured":"Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358:1580\u20139.","journal-title":"N Engl J Med"},{"issue":"44","key":"8835_CR8","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.1016\/j.vaccine.2009.06.109","volume":"27","author":"AE Barskey","year":"2009","unstructured":"Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: a historical perspective on unexpected elements. Vaccine. 2009;27(44):6186\u201395.","journal-title":"Vaccine."},{"issue":"3","key":"8835_CR9","doi-asserted-by":"publisher","first-page":"ofu094","DOI":"10.1093\/ofid\/ofu094","volume":"1","author":"AP Fiebelkorn","year":"2014","unstructured":"Fiebelkorn AP, Coleman LA, Belongia EA, Freeman SK, York D, Bi D, et al. Mumps antibody response in young adults after a third dose of Measles-Mumps-Rubella vaccine. Open Forum Infect Dis. 2014;1(3):ofu094.","journal-title":"Open Forum Infect Dis"},{"key":"8835_CR10","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/ijerph15081618","volume":"15","author":"A Beleni","year":"2018","unstructured":"Beleni A, Borgmann S. Mumps in the vaccination age: global epidemiology and the situation in Germany. Int J Environ Res Public Health. 2018;15:1618.","journal-title":"Int J Environ Res Public Health"},{"key":"8835_CR11","unstructured":"National Institute for Communicable Diseases. Notifiable Medical Conditions [Online]. Accessed 20 Apr 2020. Available: https:\/\/j9z5g3w2.stackpathcdn.com\/wp-content\/uploads\/2018\/10\/Notifiable-Medical-Condition_Z-foldBleed20-July2018.pdf."},{"key":"8835_CR12","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2019 global summary. [Online]. Last updated 10 Dec 2019. Accessed 08 Apr 2020. Available: https:\/\/apps.who.int\/immunization_monitoring\/globalsummary."},{"key":"8835_CR13","unstructured":"World Health Organization. Weekly Epidemiological Record. Mumps virus vaccines; WHO position paper. [Online]. Last updated 16 Feb 2007. Accessed 09 Apr 2020. Available: https:\/\/www.who.int\/wer\/2007\/wer8207.pdf?ua=1."},{"issue":"4","key":"8835_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jcv.2011.12.022","volume":"53","author":"J Hassan","year":"2012","unstructured":"Hassan J, Dean J, Moss E, Carr MJ, Hall WW, Connell J. Seroepidemiology of the recent mumps virus outbreaks in Ireland. J Clin Virol. 2012 Apr;53(4):320\u20134.","journal-title":"J Clin Virol"},{"issue":"25","key":"8835_CR15","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1016\/j.vaccine.2019.05.002","volume":"37","author":"EZ Sambala","year":"2019","unstructured":"Sambala EZ, Wiyeh A, Ngcobo N, Machingaidze S, Wiysonge CS. New vaccine introductions in Africa before and during the decade of vaccines \u2013 are we making progress? Vaccine. 2019;37(25):3290\u20135.","journal-title":"Vaccine."},{"issue":"1","key":"8835_CR16","first-page":"29","volume":"31","author":"M Brauer","year":"2016","unstructured":"Brauer M, Wolfaardt M, Webber LM, Taylor MB. Molecular detection and characterisation of mumps virus in cerebrospinal fluid in a Gauteng laboratory. South African J Infect Dis. 2016;31(1):29\u201331.","journal-title":"South African J Infect Dis"},{"key":"8835_CR17","unstructured":"Motaze NV, Suchard M, Cohen C, Baker L, Blumberg L, ed. Vaccine information for parents and caregivers. Johannesburg: Ideas Wise and Wonderful for National Institute for Communicable Diseases, 2016. [cited 2018 April 20]. Available at: http:\/\/www.nicd.ac.za\/assets\/files\/NICD_Vaccine_Booklet_D132_FINAL.pdf."},{"key":"8835_CR18","unstructured":"National Health Laboratory Service. Who we are. [Online]. Accessed 20 April 2018. Available from: hhtp:\/\/www.nhls.ac.za\/?page=who_are_we&id=17."},{"key":"8835_CR19","unstructured":"Statistics South Africa. Statistics release P0302. Mid-year population estimates Vol. P0302. 2011. [Online]. Accessed 5 May 2018. Available: http:\/\/www.statssa.gov.za\/publications\/P0302\/P03022011.pdf."},{"key":"8835_CR20","unstructured":"Statistics South Africa. Statistical release P0302. Mid-year population estimates Vol. P0302. 2013. [Online]. Accessed 5 May 2018. Available: https:\/\/www.statssa.gov.za\/publications\/P0302\/P03022013.pdf."},{"key":"8835_CR21","unstructured":"Statistics South Africa. Statistical release P0302. Mid-year population estimates Vol. P0302. 2014. [Online]. Accessed 5 May 2018. Available: https:\/\/www.statssa.gov.za\/publications\/P0302\/P03022014.pdf."},{"key":"8835_CR22","unstructured":"Statistics South Africa. Statistical release P0302. Mid-year population estimates Vol. P0302. 2015. [Online]. Accessed 5 May 2018. Available: https:\/\/www.statssa.gov.za\/publications\/P0302\/P03022015.pdf."},{"key":"8835_CR23","unstructured":"Statistics South Africa. Statistical release P0302. Mid-year population estimates Vol. P0302. 2016. [Online]. Accessed 5 May 2018. Available: https:\/\/www.statssa.gov.za\/publications\/P0302\/P03022016.pdf."},{"key":"8835_CR24","unstructured":"Statistics South Africa. Statistical release P0302. Mid-year population estimates Vol. P0302. 2017. [Online]. Accessed 5 May 2018. Available: http:\/\/www.statssa.gov.za\/publications\/P0302\/P03022017.pdf."},{"issue":"5","key":"8835_CR25","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3390\/ijerph17051686","volume":"17","author":"SB Su","year":"2020","unstructured":"Su SB, Chang HL, Chen AK. Current status of mumps virus infection: epidemiology, pathogenesis, and vaccine. Int J Environ Res Public Health. 2020;17(5):1686.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"8835_CR26","doi-asserted-by":"publisher","first-page":"e1004791","DOI":"10.1371\/journal.ppat.1004791","volume":"11","author":"DR Latner","year":"2015","unstructured":"Latner DR, Hickman CJ. Remembing Mumps. PLoS Pathog. 2015;11(5):e1004791.","journal-title":"PLoS Pathog"},{"key":"8835_CR27","doi-asserted-by":"publisher","first-page":"e00151","DOI":"10.1128\/CMR.00151-19","volume":"33","author":"E Lam","year":"2020","unstructured":"Lam E, Rosen JB, Zucker JR. Mumps: an update on outbreaks, vaccine efficacy, and genomic diversity. Clin Microbiol Rev. 2020;33:e00151\u201319.","journal-title":"Clin Microbiol Rev"},{"key":"8835_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.coviro.2019.01.002","volume":"34","author":"B Bankamp","year":"2019","unstructured":"Bankamp B, Hickman C, Icenogle JP, Rota PA. Successes and challenges for preventing measles, mumps and rubella by vaccination. Curr Opin Virol. 2019;34:110\u20136.","journal-title":"Curr Opin Virol"},{"issue":"34","key":"8835_CR29","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1016\/j.vaccine.2017.06.075","volume":"35","author":"N L\u00f3pez-Perea","year":"2017","unstructured":"L\u00f3pez-Perea N, Masa-Calles J. Torres de Mier M de V, Fern\u00e1ndez-Garc\u00eda a, Echevarr\u00eda JE, De Ory F, et al. shift within age-groups of mumps cumulative incidence, hospitalizations and severe complications in a highly vaccinated population. Spain, 1998\u20132014. Vaccine. 2017;35(34):4339\u201345.","journal-title":"Vaccine."},{"key":"8835_CR30","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1086\/596207","volume":"199","author":"CW LeBaron","year":"2009","unstructured":"LeBaron CW, Forghani B, Beck C, Brown C, Bi D, Cossen C. Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis. 2009;199:552\u201360.","journal-title":"J Infect Dis"},{"key":"8835_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jcv.2015.11.023","volume":"74","author":"L Kenny","year":"2016","unstructured":"Kenny L, O'Kelly E, Connell J, De Gascun C, Hassan J. Mumps outbreaks in a highly vaccinated population: investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus. J Clin Virol. 2016;74:8\u201312.","journal-title":"J Clin Virol"},{"key":"8835_CR32","first-page":"1","volume":"66","author":"M May","year":"2018","unstructured":"May M, Rieder CA, Rowe RJ. Emergent lineages of mumps virus suggest the need for a polyvalent vaccine. J Infect Dis. 2018;66:1\u20134.","journal-title":"J Infect Dis"},{"issue":"4","key":"8835_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3201\/eid2004.131681","volume":"20","author":"J Sane","year":"2014","unstructured":"Sane J, Gouma S, Koopmans M, de Melker H, Swaan C, van Binnendijk R, et al. Epidemic of mumps among vaccinated persons, the Netherlands, 2009-2012. Emerg Infect Dis. 2014;20(4):643\u20138.","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 3","key":"8835_CR34","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1093\/infdis\/jiu232","volume":"209","author":"M Muenchhoff","year":"2014","unstructured":"Muenchhoff M, Goulder PJ. Sex differences in pediatric infectious diseases. J Infect Dis. 2014;209(Suppl 3):S120\u20136.","journal-title":"J Infect Dis"},{"issue":"6","key":"8835_CR35","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1080\/21645515.2015.1029687","volume":"11","author":"YC Ho","year":"2015","unstructured":"Ho YC, Su BH, Su HJ, Chang HL, Lin CY, Chen H, et al. The association between the cumulative incidence of mumps and meteorological parameters in Taiwan. Hum Vaccin Immunother. 2015;11(6):1406\u201312.","journal-title":"Hum Vaccin Immunother"},{"key":"8835_CR36","unstructured":"South African Weather Service. Weather questions. [Online]. Accessed 15 Apr 2018. Available: https:\/\/www.weathersa.co.za\/home\/weatherques."},{"key":"8835_CR37","unstructured":"World Health Organization. WHO and UNICEF estimates of immunization coverage: 2018 revision. [online]. Last updated 2 Jul 2019. Accessed 10 Apr 2020. Available: https:\/\/www.who.int\/immunization\/monitoring_surveillance\/data\/zaf.pdf."},{"issue":"suppl 3","key":"8835_CR38","doi-asserted-by":"publisher","first-page":"C58","DOI":"10.1016\/j.vaccine.2012.02.082","volume":"30","author":"NA Cameron","year":"2012","unstructured":"Cameron NA. When, and how, should we introduce a combination measles-mumps-rubella (MMR) vaccine into the national childhood expanded immunization programme in South Africa? Vaccine. 2012;30(suppl 3):C58\u201360.","journal-title":"Vaccine."},{"issue":"7","key":"8835_CR39","first-page":"515","volume":"99","author":"BD Schoub","year":"2009","unstructured":"Schoub BD, Harris BN, McAnerney J, Blumberg L. Rubella in South Africa: an impending Greek tragedy? SAMJ. 2009;99(7):515\u20139.","journal-title":"SAMJ."},{"issue":"1","key":"8835_CR40","first-page":"1","volume":"2","author":"Q Qu","year":"2017","unstructured":"Qu Q, Fang C, Zhang L, Jia W, Weng J, Li Y. A mumps model with seasonality in China. Infect Dis Model. 2017;2(1):1\u201311.","journal-title":"Infect Dis Model"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-08835-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-020-08835-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-08835-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T19:26:36Z","timestamp":1620761196000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-08835-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["8835"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-08835-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-17176\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"1 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the Faculty of Health Sciences Research Ethics Committee of the University of Pretoria (ref. 539\/2017). Institutional clearances were also obtained from the NHLS Academic Affairs, Research and Quality Assurance (for the public health sector data) as well as the relevant ethics committees of the respective private laboratories (for private health sector data).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"668"}}